• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶原激活剂和纤溶酶原与肝素的相互作用:离子强度的影响。

Interaction of plasminogen activators and plasminogen with heparin: effect of ionic strength.

作者信息

Rijken D C, de Munk G A, Jie A F

机构信息

TNO Institute of Ageing and Vascular Research (IVVO-TNO), Gaubius Laboratory, Leiden, The Netherlands.

出版信息

Thromb Haemost. 1993 Nov 15;70(5):867-72.

PMID:8128448
Abstract

In order to define the possible effects of heparin on the fibrinolytic system under physiological conditions, we studied the interactions of this drug with plasminogen and its activators at various ionic strengths. As reported in recent literature, heparin stimulated the activation of Lys-plasminogen by high molecular weight (HMW) and low molecular weight (LMW) two-chain urokinase-type plasminogen activator (u-PA) and two-chain tissue-type plasminogen activator (t-PA) 10- to 17-fold. Our results showed, however, that this stimulation only occurred at low ionic strength and was negligible at a physiological salt concentration. Direct binding studies were performed using heparin-agarose column chromatography. The interaction between heparin and Lys-plasminogen appeared to be salt sensitive, which explains at least in part why heparin did not stimulate plasminogen activation at 0.15 M NaCl. The binding of u-PA and t-PA to heparin-agarose was less salt sensitive. Results were consistent with heparin binding sites on both LMW u-PA and the amino-terminal part of HMW u-PA. Single-chain t-PA bound more avidly than two-chain t-PA. The interactions between heparin and plasminogen activators can occur under physiological conditions and may modulate the fibrinolytic system.

摘要

为了确定肝素在生理条件下对纤溶系统的可能影响,我们研究了该药物在不同离子强度下与纤溶酶原及其激活剂的相互作用。正如最近文献所报道的,肝素可使高分子量(HMW)和低分子量(LMW)双链尿激酶型纤溶酶原激活剂(u-PA)以及双链组织型纤溶酶原激活剂(t-PA)对赖氨酸纤溶酶原的激活作用增强10至17倍。然而,我们的结果表明,这种刺激仅在低离子强度下发生,而在生理盐浓度下可忽略不计。使用肝素-琼脂糖柱色谱进行直接结合研究。肝素与赖氨酸纤溶酶原之间的相互作用似乎对盐敏感,这至少部分解释了为什么肝素在0.15M NaCl时不会刺激纤溶酶原激活。u-PA和t-PA与肝素-琼脂糖的结合对盐不太敏感。结果与LMW u-PA和HMW u-PA氨基末端部分上的肝素结合位点一致。单链t-PA比双链t-PA结合更紧密。肝素与纤溶酶原激活剂之间的相互作用可在生理条件下发生,并可能调节纤溶系统。

相似文献

1
Interaction of plasminogen activators and plasminogen with heparin: effect of ionic strength.纤溶酶原激活剂和纤溶酶原与肝素的相互作用:离子强度的影响。
Thromb Haemost. 1993 Nov 15;70(5):867-72.
2
Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.肌动蛋白可通过组织型和尿激酶型纤溶酶原激活剂刺激纤溶酶的生成。
Arch Biochem Biophys. 1993 Nov 15;307(1):138-45. doi: 10.1006/abbi.1993.1572.
3
Insight into the profibrinolytic activity of dermatan sulfate: effects on the activation of plasminogen mediated by tissue and urinary plasminogen activators.深入了解硫酸皮肤素的纤溶活性:对组织型和尿激酶型纤溶酶原激活物介导的纤溶酶原激活的影响。
Thromb Res. 2007;120(5):745-52. doi: 10.1016/j.thromres.2006.12.014. Epub 2007 Jan 31.
4
Effects of a fucoidan on the activation of plasminogen by u-PA and t-PA.一种岩藻依聚糖对尿激酶型纤溶酶原激活物(u-PA)和组织型纤溶酶原激活物(t-PA)激活纤溶酶原的影响。
Thromb Res. 2000 Sep 15;99(6):623-34. doi: 10.1016/s0049-3848(00)00289-9.
5
Comparison of the in vitro fibrinolytic activities of low and high molecular weight single-chain urokinase-type plasminogen activator.低分子量和高分子量单链尿激酶型纤溶酶原激活剂的体外纤溶活性比较
Thromb Haemost. 1993 Sep 1;70(3):481-5.
6
Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.通过在纤溶酶切割位点融合获得的嵌合型(组织型/尿激酶型)纤溶酶原激活剂的特性。
Thromb Haemost. 1993 May 3;69(5):466-72.
7
Effect of oversulfation on the chemical and biological properties of chondroitin-4-sulfate.过硫酸化对硫酸软骨素-4的化学和生物学性质的影响。
Blood Coagul Fibrinolysis. 2008 Sep;19(6):483-7. doi: 10.1097/MBC.0b013e3282f2a99e.
8
Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.与溶栓治疗相关的纤维蛋白溶解的分子基础。
Thromb Haemost. 1995 Jul;74(1):167-71.
9
Potentiation by heparin fragments of thrombolysis induced with human tissue-type plasminogen activator or human single-chain urokinase-type plasminogen activator.肝素片段对人组织型纤溶酶原激活剂或人单链尿激酶型纤溶酶原激活剂诱导的溶栓作用的增强作用。
Thromb Haemost. 1987 Oct 28;58(3):947-50.
10
Alcohol-induced up-regulation of fibrinolytic activity and plasminogen activators in human monocytes.酒精诱导人单核细胞纤溶活性和纤溶酶原激活剂上调。
Alcohol Clin Exp Res. 2002 Aug;26(8):1121-7. doi: 10.1097/01.ALC.0000024358.83124.6B.

引用本文的文献

1
The safety and efficacy of intravenous administration of tranexamic acid in off-pump coronary artery bypass grafting: a systematic review and meta-analysis.静脉注射氨甲环酸在非体外循环冠状动脉旁路移植术中的安全性和有效性:一项系统评价和荟萃分析。
Front Med (Lausanne). 2025 Sep 5;12:1643712. doi: 10.3389/fmed.2025.1643712. eCollection 2025.
2
The safety and efficiency of intravenous administration of tranexamic acid in coronary artery bypass grafting (CABG): a meta-analysis of 28 randomized controlled trials.静脉注射氨甲环酸在冠状动脉旁路移植术(CABG)中的安全性和有效性:28 项随机对照试验的荟萃分析。
BMC Anesthesiol. 2019 Jun 14;19(1):104. doi: 10.1186/s12871-019-0761-3.
3
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.
血管生成中肝素/硫酸乙酰肝素蛋白聚糖糖组相互作用组:生物学意义与治疗应用
Molecules. 2015 Apr 10;20(4):6342-88. doi: 10.3390/molecules20046342.